NIBR’s research centers on the patient, and that begins with understanding patients’ evolving medical needs. Where high unmet medical needs intersect with deep understanding of disease biology, NIBR embarks on drug discovery programs.
NIBR’s research platforms combine advanced technologies and sound science to support Novartis’ goal to deliver safe and effective medicines to patients. Before potential treatments enter clinical trials, NIBR’s platform scientists play a major role in ensuring that compounds have the best chance of success.
NIBR’s research platforms—which specialize in fields ranging from chemistry to toxicology to translational medicine—reflect the massive effort behind each project advancing toward clinical development. Importantly, NIBR’s approach to drug discovery emphasizes teamwork and collaboration among these platforms.